Cornelia Dunger‐Baldauf

Testing and estimation in flexible group sequential designs with adaptive treatment selection

Martin Posch, Franz Koenig, Michael Branson et al. · Statistics in Medicine · 2005 · 225 citations · Full text

RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Frank G. Holz, Marta S. Figueroa, Francesco Bandello et al. · Retina · 2019 · 100 citations · Full text

Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects

Joel Morganroth, Peter C. Rüegg, Cornelia Dunger‐Baldauf et al. · The American Journal of Gastroenterology · 2002 · 70 citations

Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study

Paul Mitchell, Tom Sheidow, Michel Eid Farah et al. · PLoS ONE · 2020 · 52 citations · Full text

Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome

Salam Zakko, Gary Barton, Eckhard Weber et al. · Alimentary Pharmacology & Therapeutics · 2011 · 30 citations · Full text